Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 5 | 2025 | 8 | 2.720 |
Why?
|
| Retinal Neovascularization | 2 | 2025 | 29 | 1.550 |
Why?
|
| Choroidal Neovascularization | 3 | 2025 | 56 | 1.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2025 | 212 | 0.760 |
Why?
|
| Transcriptional Activation | 1 | 2025 | 372 | 0.750 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2025 | 298 | 0.740 |
Why?
|
| Diabetic Retinopathy | 4 | 2025 | 211 | 0.670 |
Why?
|
| Endothelial Cells | 2 | 2025 | 878 | 0.590 |
Why?
|
| Oxidation-Reduction | 4 | 2025 | 1069 | 0.500 |
Why?
|
| Retinopathy of Prematurity | 3 | 2025 | 181 | 0.490 |
Why?
|
| Apolipoprotein E4 | 2 | 2026 | 42 | 0.440 |
Why?
|
| Retina | 3 | 2026 | 331 | 0.400 |
Why?
|
| Macular Degeneration | 2 | 2023 | 191 | 0.310 |
Why?
|
| Mice | 7 | 2026 | 18358 | 0.240 |
Why?
|
| Epoxide Hydrolases | 2 | 2023 | 13 | 0.240 |
Why?
|
| Apolipoprotein E3 | 1 | 2026 | 4 | 0.240 |
Why?
|
| Diet, Western | 1 | 2026 | 88 | 0.220 |
Why?
|
| Propionates | 1 | 2025 | 39 | 0.220 |
Why?
|
| Benzoquinones | 1 | 2025 | 46 | 0.220 |
Why?
|
| Diet, High-Fat | 1 | 2026 | 266 | 0.210 |
Why?
|
| beta Catenin | 1 | 2025 | 254 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2023 | 552 | 0.180 |
Why?
|
| Animals | 7 | 2026 | 38106 | 0.170 |
Why?
|
| Intravitreal Injections | 1 | 2021 | 71 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 5995 | 0.150 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 293 | 0.140 |
Why?
|
| Administration, Oral | 1 | 2021 | 867 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 630 | 0.140 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 821 | 0.130 |
Why?
|
| Models, Molecular | 1 | 2021 | 1599 | 0.120 |
Why?
|
| Gene Knock-In Techniques | 2 | 2026 | 61 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2021 | 1361 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 928 | 0.100 |
Why?
|
| Humans | 8 | 2026 | 145785 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2026 | 2192 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4568 | 0.070 |
Why?
|
| Electroretinography | 1 | 2025 | 51 | 0.050 |
Why?
|
| Gliosis | 1 | 2025 | 30 | 0.050 |
Why?
|
| Receptors, LDL | 1 | 2025 | 53 | 0.050 |
Why?
|
| Glucose Intolerance | 1 | 2026 | 142 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2023 | 78 | 0.050 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 31 | 0.050 |
Why?
|
| Tomography, Optical Coherence | 1 | 2025 | 270 | 0.050 |
Why?
|
| Choroid | 1 | 2022 | 80 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2023 | 239 | 0.040 |
Why?
|
| DNA Repair | 1 | 2023 | 255 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2025 | 3130 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2022 | 2805 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2023 | 1736 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 2885 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2023 | 6465 | 0.020 |
Why?
|
| Male | 2 | 2026 | 73012 | 0.020 |
Why?
|